Through this series of webinars, we will explore the emerging hearing medicines landscape by inviting leading clinicians, academics and industry representatives along with people with lived experience of hearing loss, to share their expertise and insight.
What’s it about?
To provide an introduction to the promise of cell and gene therapies for the treatment of hearing loss, and provide a forum for discuss the challenges and opportunities of this emerging therapeutic modality and its application for hearing loss.
Who should join?
Anyone interested in learning more about hearing drug discovery, or people working in regenerative medicine and interested in learning about new applications.
Will I be able to join if I have hearing loss?
Yes, the webinar will be BSL-interpreted and scripted in real-time by a professional typist to enable people with hearing loss to join and interact with the live event.
15:30 Welcome and introduction
Dr Ralph Holme, Action on Hearing Loss, Dr Sam Goldsmith, Cell and Gene Therapy Catapult, and Dr Francesca Glibuich, London Advanced Therapies
15:40 Gene therapies for hearing loss
Prof Karen Avraham, Tel Aviv University
16:00 Cell therapies for hearing loss
Prof Marcelo Rivolta, Rinri Therapeutics
16:20 Panel discussion: What are the key opportunities and challenges for cell and gene therapies for hearing loss?